Skip to main
DNA
DNA logo

DNA Stock Forecast & Price Target

DNA Analyst Ratings

Based on 10 analyst ratings
Hold
Strong Buy 40%
Buy 10%
Hold 20%
Sell 10%
Strong Sell 20%
DNA has been analyzed by 10 analysts, with a consensus rating of Hold. 40% of analysts recommend a Strong Buy, 10% recommend Buy, 20% suggest Holding, 10% advise Selling, and 20% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ginkgo Bioworks Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ginkgo Bioworks Holdings (DNA) Forecast

Analysts have given DNA a Hold based on their latest research and market trends.

According to 10 analysts, DNA has a Hold consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $6.02, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $6.02, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ginkgo Bioworks Holdings (DNA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.